Pfizer delivers strong Q1 but keeps guidance steady amid COVID seasonality
5th May 2026 Uncategorised 0With a better-than-expected first quarter in the books, Pfizer—continuing to grapple with the post-pandemic overhang from its COVID-19 franchise—is sticking with the sales forecast it set earlier this year, raising questions from at least one analyst about whether it could have lifted its outlook.
More: Pfizer delivers strong Q1 but keeps guidance steady amid COVID seasonality
Source: fierce